Vib4920.P2.S3
Research payments
$317,090
Through program year 2021, $317,090 in research payments was reported against Vib4920.P2.S3, across 17 payments, paid by Horizon Therapeutics plc.
- Paid by
- Horizon Therapeutics plc
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $317,090 | 17 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Alan Kivitz Duncansville, PA Named on 1 payment
- Jane Box Charlotte, NC Named on 1 payment
- Robert Levin Clearwater, FL Named on 1 payment
- Sabeen Najam Baytown, TX Named on 1 payment
- Jigar Shah Margate, FL Named on 1 payment
- David Sikes Zephyrhills, FL Named on 1 payment
- Jeffrey Neal Lexington, KY Named on 1 payment
- Gregory Gottschlich Cincinnati, OH Named on 1 payment
- Paul Demarco Wheaton, MD Named on 1 payment
- Gary Myerson Atlanta, GA Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.